Literature DB >> 5649642

The release of nucleotides, 5-hydroxytryptamine and enzymes from human blood platelets during aggregation.

D C Mills, I A Robb, G C Roberts.   

Abstract

1. Adenosine diphosphate (ADP) and adrenaline caused the aggregation of human platelets suspended in plasma containing citrate anticoagulant and stirred at 37 degrees C. The aggregation occurred in two phases and the second phase was associated with the appearance in the plasma of up to 30% of the ATP and 55% of the ADP present in the platelets. The concentration of ADP appearing in the plasma was up to 7 times the concentration added.2. Radioactivity was released by ADP and by adrenaline from platelets labelled with radioactive 5-hydroxytryptamine; this release was closely correlated with the second phase of aggregation and with the release of nucleotides.3. Acid phosphatase, beta-glucuronidase and adenylate kinase were released to a small extent during second phase aggregation by ADP or adrenaline; thrombin and collagen particles caused significantly greater release of beta-glucuronidase than of either acid phosphatase or of adenylate kinase.4. Morphological changes indicating degranulation of the platelets were observed during the second phase of aggregation produced by adrenaline and by ADP.5. The second phase of aggregation, degranulation of platelets, and the release of nucleotides, of labelled 5-hydroxytryptamine and of enzymes, were all inhibited by concentrations of amitriptyline which did not inhibit aggregation.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5649642      PMCID: PMC1351696          DOI: 10.1113/jphysiol.1968.sp008484

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  33 in total

1.  Studies on human platelet granules and membranes.

Authors:  A J Marcus; D Zucker-Franklin; L B Safier; H L Ullman
Journal:  J Clin Invest       Date:  1966-01       Impact factor: 14.808

2.  Changes in platelet volume produced by temperature, metabolic inhibitors, and aggregating agents.

Authors:  B S Bull; M B Zucker
Journal:  Proc Soc Exp Biol Med       Date:  1965-11

3.  Intracellular distribution of monoamine oxidase, 5-hydroxytryptamine and histamine in blood platelets of rabbit.

Authors:  E Solatunturi; M K Paasonen
Journal:  Ann Med Exp Biol Fenn       Date:  1966

4.  Formation of 5-hydroxytryptophol by blood platelets after thrombin and reserpine.

Authors:  M da Prada; G Bartholini; A Pletscher
Journal:  Experientia       Date:  1965-03-15

5.  Effects of the numbers and sizes of platelet aggregates on the optical density of plasma.

Authors:  G V Born; M Hume
Journal:  Nature       Date:  1967-09-02       Impact factor: 49.962

6.  Secondary clumping effect in human citrated platelet-rich plasma produced by adenosine diphosphate and adrenaline.

Authors:  D C Macmillan
Journal:  Nature       Date:  1966-07-09       Impact factor: 49.962

7.  Microdetermination of adenosine diphosphate and adenosine triphosphate in plasma with firefly luciferase system.

Authors:  H Holmsen; I Holmsen; A Bernhardsen
Journal:  Anal Biochem       Date:  1966-12       Impact factor: 3.365

8.  Platelet aggregation and the availability of platelet factor 3.

Authors:  R M Hardisty; R A Hutton
Journal:  Br J Haematol       Date:  1966-11       Impact factor: 6.998

9.  Studies on human platelet glycolysis. Effect of glucose, cyanide, insulin, citrate, and agglutination and contraction on platelet glycolysis.

Authors:  S Karpatkin
Journal:  J Clin Invest       Date:  1967-03       Impact factor: 14.808

10.  The adenylate kinase of human plasma, erythrocytes and platelets in relation to the degradation of adenosine diphosphate in plasma.

Authors:  R J Haslam; D C Mills
Journal:  Biochem J       Date:  1967-06       Impact factor: 3.857

View more
  52 in total

1.  Role of catalytic function in the antiplatelet activity of phospholipase A2 cobra (Naja naja naja) venom.

Authors:  L M Rudrammaji; K D Machiah; T P Kantha; T V Gowda
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

2.  Potentiation of ADP-induced aggregation in human platelet-rich plasma by 5-hydroxytryptamine and adrenaline.

Authors:  D M Vanags; S E Rodgers; E M Duncan; J V Lloyd; F Bochner
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

Review 3.  Antiplatelet drugs.

Authors:  Gustav Born; Carlo Patrono
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

Review 4.  Antiplatelet drug 'resistance'. Part 2: laboratory resistance to antiplatelet drugs-fact or artifact?

Authors:  Diana A Gorog; Joseph M Sweeny; Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2009-04-14       Impact factor: 32.419

5.  Role of PTEN in modulation of ADP-dependent signaling pathways in vascular endothelial cells.

Authors:  Rosa Bretón-Romero; Hermann Kalwa; Santiago Lamas; Thomas Michel
Journal:  Biochim Biophys Acta       Date:  2013-06-25

Review 6.  P2 receptor subtypes in the cardiovascular system.

Authors:  S P Kunapuli; J L Daniel
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

7.  Single nucleotide polymorphisms of the purinergic 1 receptor are not associated with myocardial infarction in a Latvian population.

Authors:  Vita Ignatovica; Gustavs Latkovskis; Raitis Peculis; Kaspars Megnis; Helgi B Schioth; Iveta Vaivade; Davids Fridmanis; Valdis Pirags; Andrejs Erglis; Janis Klovins
Journal:  Mol Biol Rep       Date:  2011-06-04       Impact factor: 2.316

8.  Secretory mechanisms. Behaviour of adenine nucleotides during the platelet release reaction induced by adenosine diphosphate and adrenaline.

Authors:  H Holmsen; H J Day; C A Setkowsky
Journal:  Biochem J       Date:  1972-08       Impact factor: 3.857

Review 9.  Blood platelets in human essential hypertension.

Authors:  F De Clerck
Journal:  Agents Actions       Date:  1986-08

10.  ADP signaling in vascular endothelial cells: ADP-dependent activation of the endothelial isoform of nitric-oxide synthase requires the expression but not the kinase activity of AMP-activated protein kinase.

Authors:  Connie Ng Hess; Ruqin Kou; Rosalyn P Johnson; Gordon K Li; Thomas Michel
Journal:  J Biol Chem       Date:  2009-09-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.